Phase 2 Peanut allergy Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants
Peanut allergy
N-Fold, LLC68 enrolled1 locationNCT07117669
Recruiting
Phase 2
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Milk and/or Peanut Allergy
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT03835767
Recruiting
Phase 1Phase 2
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Peanut allergyPeanut-Induced Anaphylaxis
Ukko Inc40 enrolled5 locationsNCT07349212
Recruiting
Phase 2
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Food allergyPeanut allergyFood Allergy Peanut+3 more
Rima Rachid37 enrolled1 locationNCT05695261
Recruiting
Phase 1Phase 2
Oral Immunotherapy for Peanut Allergic Patients
Peanut allergy
InnoUp Farma S.L.50 enrolled2 locationsNCT04163562
Recruiting
Phase 1Phase 2
VE416 for Treatment of Food Allergy
Peanut allergy
Massachusetts General Hospital60 enrolled1 locationNCT03936998
Recruiting
Phase 2
HYPES: Peanut allergy desensitisation using sequential hypoallergenic and roasted peanuts
Peanut allergy
Dr Tim Chataway75 enrolled1 locationACTRN12617000803392
Completed
Phase 2
Study of the effectiveness of Probiotics and Peanut Oral Immunotherapy (P-POIT) in inducing desensitisation or tolerance in children with peanut allergy
Peanut allergy
Royal Children's Hospital90 enrolled1 locationACTRN12608000594325